This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Stephanie Bignon
Stephanie W. Bignon
Associate
Washington +1 202 662 5393 sbignon@cov.com Download V-card

Stephanie W. Bignon is a corporate associate in the firm’s Washington, DC office.  Her practice focuses on advising public companies with respect to securities law matters, including, for example, capital markets transactions and securities disclosure and compliance issues.

  • Represented Eli Lilly and Company in a $1.0 billion registered offering of notes, consisting of $600.0 million of 1.950% notes due 2019 and $400.0 million of 4.650% notes due 2044.
  • Represented Salix Pharmaceuticals, Ltd. in its $750 million offering of 6.00% senior notes due 2021 in connection with its $2.6 billion acquisition of Santarus, Inc.
  • Represented the National Football League in connection with various league and stadium financings and ownership transactions, including its G-4 stadium funding program.
  • Assists Fortune 500 and other public companies in the preparation of periodic reports under the Securities Exchange Act of 1934 and on other securities law compliance matters, including under the Dodd-Frank Act.

Pro Bono

  • Drafted corporate organizational and governing documents for a non-profit organization and advised on corporate governance issues.
  • Represented a client in connection with a petition by the probation office to revoke supervised release.

Previous Experience

  • Senior External Reporting Analyst in the External Financial Reporting group at Delta Air Lines (2007-2008).
  • Assurance Associate (2005-2007) and Senior Assurance Associate (2007) at Grant Thornton LLP.